This article is from: srnnews.com
March 2 (Reuters) – United Therapeutics said on Monday its experimental pill for a type of blood pressure disorder met all the main and secondary goals of a late-stage study.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Vijay Kishore)
Brought to you by www.srnnews.com
